In studying the regulation of Src by Csk, we and others have noticed a correlation between Src protein levels and expression of Csk [11, 12] . To determine whether Csk could directly affect the level of Src expression, we infected csk-deficient cells with a retroviral vector encoding either wild-type Csk or a catalytically inactive mutant in which amino-acid residue 222 was mutated to arginine (Csk R222); csk -/-cells infected with empty vector were used as controls. The activity of endogenous Src family kinases was assessed by immunoblot analysis of cell lysates with anti-phosphotyrosine antibody. As reported previously [13] , the kinase activity of Src family members was strongly inhibited by expression of wild-type Csk, but not by expression of Csk R222 (Figure 1b) . The levels of Src and Fyn were determined by immunoblot analysis of cell lysates (Figure 1b) . When wild-type Csk was expressed in csk -/-cells, the cells had over fivefold higher Src protein levels and over fourfold higher Fyn protein levels than the same cells infected with the empty vector ( Figure 1a) ; csk -/-cells expressing Csk R222 contained only slightly elevated levels of Src and Fyn proteins. To further characterize the effects of Csk on the level of Src protein, csk -/-clones expressing comparable levels of wildtype Csk or Csk R222 were generated by transfection. Src protein levels were approximately threefold higher in clones expressing wild-type Csk than in control clones transfected with empty vector or those expressing Csk R222 (Figures 1c,d) . Thus, catalytically active Csk induces an increase in the abundance of Src and Fyn protein, whereas catalytically inactive Csk induces at most a small increase. These data suggest that inactivation of Src and Fyn by Csk protects them from some mechanism that downregulates their abundance.
Results and discussion
In studying the regulation of Src by Csk, we and others have noticed a correlation between Src protein levels and expression of Csk [11, 12] . To determine whether Csk could directly affect the level of Src expression, we infected csk-deficient cells with a retroviral vector encoding either wild-type Csk or a catalytically inactive mutant in which amino-acid residue 222 was mutated to arginine (Csk R222); csk -/-cells infected with empty vector were used as controls. The activity of endogenous Src family kinases was assessed by immunoblot analysis of cell lysates with anti-phosphotyrosine antibody. As reported previously [13] , the kinase activity of Src family members was strongly inhibited by expression of wild-type Csk, but not by expression of Csk R222 (Figure 1b) . The levels of Src and Fyn were determined by immunoblot analysis of cell lysates (Figure 1b) . When wild-type Csk was expressed in csk -/-cells, the cells had over fivefold higher Src protein levels and over fourfold higher Fyn protein levels than the same cells infected with the empty vector ( Figure 1a) ; csk -/-cells expressing Csk R222 contained only slightly elevated levels of Src and Fyn proteins. To further characterize the effects of Csk on the level of Src protein, csk -/-clones expressing comparable levels of wildtype Csk or Csk R222 were generated by transfection. Src protein levels were approximately threefold higher in clones expressing wild-type Csk than in control clones transfected with empty vector or those expressing Csk R222 (Figures 1c,d ). Thus, catalytically active Csk induces an increase in the abundance of Src and Fyn protein, whereas catalytically inactive Csk induces at most a small increase. These data suggest that inactivation of Src and Fyn by Csk protects them from some mechanism that downregulates their abundance.
To determine whether the regulation of Src protein expression occurs at the transcriptional level, we analyzed the levels of src and fyn mRNA in csk -/-cells expressing wild-type Csk, Csk R222, or empty vector. Neither wildtype Csk nor Csk R222 expression affected the level of src message (Figure 1e ). The level of fyn mRNA was also unaffected by Csk expression (data not shown). Thus, downregulation of Src protein levels occurs through a post-transcriptional mechanism.
A possible explanation for the effect of Csk expression on Src abundance is that phosphorylation by Csk affects the turnover rate of the molecule. Pulse-chase experiments were therefore performed to determine the stability of Src protein in csk -/-cells expressing empty vector or wild-type Csk (Figure 2a ). Similar levels of pulse-labeled Src protein were detected in the two cell types, indicating that Csk did not affect the rate of synthesis of Src. The half-life of Src in csk -/-cells re-expressing wild-type Csk was 12 hours (Figure 2b ). In csk -/-cells expressing empty vector, however, Src had a more rapid turnover rate, with an approximately 4.5 hour half-life. The levels of [ 35 S]methionine label incorporated and the rates of turnover of total cellular protein were similar in the two cell types, indicating that the effect of Csk on Src turnover was not due to a general effect on the turnover of cellular proteins ( Figure 2c ). Thus, inactivation of Src by Csk protects Src from degradation. Proteins that are covalently conjugated to the 76 amino acid ubiquitin molecule are recognized as targets for Figure 3 ).
Overexpression of wild-type Src in the presence of HA-ubiquitin resulted in the formation of an electrophoretically-retarded form of Src with an apparent molecular weight of ~68 kDa (compare lanes 2 and 3). This electrophoretically retarded form of Src had the same mobility as a band in the blot probed with anti-HA antibody and presumably represents a monoubiquitinated form of Src (compare lanes 2 and 3 with lanes 7 and 8). As the monoubiquitinated form was not seen with Src alone, its formation could reflect HA-ubiquitin overexpression, and it may not be on the pathway to polyubiquitination. Coexpression of HA-ubiquitin with activated Src (Src Y527F), resulted in the formation of the same electrophoretically-retarded form of Src at 68 kDa (lanes 4 and 9). Src Y527F was also found in polyubiquitinated forms (compare lanes 4 and 9 with lanes 3 and 8), indicating that activated Src is more extensively ubiquitinated than the wild-type form.
Expression of conformationally open but catalytically inactive Src, Src K295R Y527F, did not result in the formation of polyubiquitinated species (lanes 5 and 10).
Therefore, an open conformation is not sufficient for Src polyubiquitination, whereas catalytic activity is required. This would suggest that Src either activates a signaling pathway that targets it for degradation, or that autophosphorylation (there is a known autophosphorylation site at Tyr416 in Src) is required for recognition of the molecule by the ubiquitinating machinery. It will be difficult to differentiate between these possibilities as autophosphorylation at Tyr416 is required for complete c-Src catalytic activity [1] . These data indicate that ubiquitination is promoted by Src activation.
We conclude that Src kinase activity can be downregulated, not only by inactivation by Csk, but also by ubiquitin-proteasome-dependent degradation. Phosphorylation by Csk induces a conformational change in Src through intramolecular interactions that convert it from the open to the closed conformation. Activated Src molecules that escape this mode of regulation are susceptible to degradation by ubiquitin-proteasome-dependent degradation. Phosphorylation by Csk and consequent folding of Src into the inactive form may directly protect Src from being recognized by the ubiquitination machinery. Another possibility is that activated Src may itself activate the machinery responsible for its own ubiquitination. Irrespective of the mechanism involved, downregulation of active Src by degradation represents an additional mechanism by which the activity of Src family members can be regulated. Elevated levels of Src protein are found in many colon carcinomas [4] with mutational activation also occurring in advanced metastatic forms [5] . Thus the ligase responsible for Src ubiquitination represents a potential tumor suppressor, and a defect in ubiquitin-proteasome-dependent degradation of Src might potentiate the development of some carcinomas.
Supplementary material
Supplementary material including additional methodological details is available at http://current-biology.com/supmat/supmatin.htm. 
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